Research

Medical Sciences

Title :

Development of small molecular inhibitor specifically targeting MTORC2 for cancer therapeutics: Development of targeted anti-cancer strategy

Area of research :

Life Sciences & Biotechnology, Medical Sciences

Focus area :

Cancer therapeutics

Principal Investigator :

Dr. Smrati Bhadauria, Scientist, Central Drug Research Institute (CDRI), Lucknow, Uttar Pradesh

Timeline Start Year :

2017

Contact info :

Details

Total Budget (INR):

 40,83,200

Organizations involved

Implementing Agency :

Central Drug Research Institute (CDRI), Lucknow, Uttar Pradesh

Funding Agency :

Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India

Related Research

Development of Shield for Pulmonologist. Hardware development using FRP soft materials to protect the Pulmonologist during Medicare
Neuroprotective Phytoceutical NEURO-STRIPS for Alzheimer's disease
Studies on potential of natural garlic essential oil as a potential inhibitor of ACE2 protein and the main protease PDB6LU7 of SARS-CoV-2
Prevention of maternal and neonatal death/infections with a single oral dose of azithromycin in women in labor (in low- and middle-income countries): a randomized controlled trial: The A PLUS Study
Impact of improved diagnostic tools, practices, training and communication on acute fever case management and antibiotic prescriptions for children, adolescents and adults presenting at outpatient facilities of R D Gardi Medical College, Ujjain, India